This letter addresses a number of discrepancies found in several publications related HMB-FA and ATP supplementation.
HMB+ ATP group. For all 3 papers half of the subjects would be identical."
Inconsistent descriptions of control groups between papers. According to the 2013 Wilson et al. article [1] , subjects consumed the following supplement or placebo, "Prior to the study, participants were randomly assigned to receive either 400 mg per day of ATP disodium or maltodextrin (placebo)…" This description conflicts with the stated placebo protocol according to ClinicalTrials.-gov [4] . Furthermore, in Wilson et al. [2] , neither the placebo or HMB supplement protocols, match those described in Wilson et al. [1] or ClinicalTrials.gov [4] . Finally, Lowery et al. [3] is the only paper of the three, where the placebo and HMB + ATP supplement protocols match what is described on ClinicalTrials.gov [4] , but this does not match the previous two papers. Could the authors explain how the reported placebo groups followed different supplement protocols, while simultaneously being in the same placebo group for the study?
Differing number of subjects in control groups between papers. In Wilson et al. [1] , 3 subjects dropped due to injury leaving 11 in the ATP group and 10 in the placebo group. In Wilson et al. [2] , 3 subjects dropped from the placebo group (2 due to injury and 1 for time commitment) and 1 from the HMB-FA group due to injury. In Lowery et al. [3] , there were 9 in the placebo group and 8 in the HMB + ATP group with no explanation of why subjects dropped. Considering the evidence already provided establishing that all three publications are a result of the same study, and that the placebo group contained the same subjects, it would follow that the placebo group would be the same size in each publication. Equally troubling, is the absence of an explanation for dropouts and the original number of subjects in Lowery et al. [3] . Can the authors explain the discrepancies in the number of dropouts and reasons for dropout in Wilson et al. [1] , Wilson et al. [2] and Lowery et al. [3] ?
Extraordinary homogeneity between papers. [3] . These mean values represent the entire sample in each publication, not the means for each treatment groups. As can be seen, the samples in each publication have nearly identical means and SDs for age and 1RM strength relative to body mass for squat, bench press, and deadlift. The PI for the study communicated the following "…for any other group at the beginning of a study you can stratify subjects into groups so that body mass and strength are nearly identical. Thats [sic] the goal of any study to stratify not just so means are similar but also standard deviations." [5] There are a number of issues with this explanation. Could the authors explain how this level homogeneity was achieved between all 3 publications with the absence of consistent subject/group matching, different sample sizes, and a different number of dropouts in placebo and treatment groups?
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